Abstract Details

Title Attempted Validation of the CARE Carotid Stenting Risk Score

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P06 - (-)

Poster/Presentation
Number 261

Objective

Background BACKGROUND: In hospital complications of carotid artery stenting (CAS) remain a major concern. Recently, the CARE registry investigators presented an internally validated score to help predict in-hospital complications from CAS, with the greatest weightage to increasing age, followed by impending major surgery, previous stroke, symptomatic status, previous stroke and contralateral occlusion. We attempted to externally validate the CARE carotid stenting risk score in our CAS population.

Design/Methods DESIGN/METHODS: We performed a retrospective review of CAS procedures between June 2009 and April 2012 at an urban medical center. We included all patients where every risk factor was documented. In-hospital outcomes of stroke/death and/or myocardial infarction (MI) were recorded.

Results RESULTS: A total of 139 CAS procedures met the inclusion criteria. Most common risk factor was prior stroke (25.9%) followed by A fib (14.4%). Most patients were between 60-90 years (60-69: 35.3%; 70-79: 27.3%; 80-89: 25.9%). There were 10 (7.2%) post op complications (9 strokes, 1 MI and 0 death). Most patients had a CARE score between 4 and 9. However, the CARE carotid stenting risk score did not correlate well with in-hospital complications in this series.

Conclusions CONCLUSIONS: CARE carotid stenting risk score did not correlate with outcome in our population. External validation in a much larger dataset with sufficient number of outcome events is required.

Authors/Disclosures
Shahram Khalid, MD (Neurology Care PLLC) PRESENTER	No disclosure on file
Mahmoud Rayes, MD	No disclosure on file
Pratik D. Bhattacharya, MD, MPH (International Medical Clinic)	Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Jeffrey A. Cohen, MD (Cleveland Clinic)	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Seemant Chaturvedi, MD, FAHA, FAAN (University of Maryland)	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.

��ɫ��

��ɫ��